Hypertension Treatment-JNC 8 2014
Hypertension Treatment-JNC 8 2014 - Flowchart
«Flowchart»

LIFESTYLE MODIFICATIONS
Weight reduction
DASH/Mediterranean diet
Dietary sodium restriction
Exercise
Moderate ETOH
Cessation of smoking
K supplementation in diet (ADA, CHEP)

LIFESTYLE MODIFICATIONS
Weight reduction
DASH/Mediterranean diet
Dietary sodium restriction
Exercise
Moderate ETOH
Cessation of smoking
K supplementation in diet (ADA, CHEP)

LIFESTYLE MODIFICATIONS
Weight reduction
DASH/Mediterranean diet
Dietary sodium restriction
Exercise
Moderate ETOH
Cessation of smoking
K supplementation in diet (ADA, CHEP)

LIFESTYLE MODIFICATIONS






SPECIAL GROUPS
African-Americans without CKD: initiate with CCBs and thiazide
Patients with CKD regardless of race: initiate with ACEI or ARBs
DO NOT COMBINE ACEI with ARBs
In patients >75 y with CKD, use CCB and thiazide-type diuretic instead of ACEI/ARBs

SPECIAL GROUPS
African-Americans without CKD: initiate with CCBs and thiazide
Patients with CKD regardless of race: initiate with ACEI or ARBs
DO NOT COMBINE ACEI with ARBs
In patients >75 y with CKD, use CCB and thiazide-type diuretic instead of ACEI/ARBs

SPECIAL GROUPS
African-Americans without CKD: initiate with CCBs and thiazide
Patients with CKD regardless of race: initiate with ACEI or ARBs
DO NOT COMBINE ACEI with ARBs
In patients >75 y with CKD, use CCB and thiazide-type diuretic instead of ACEI/ARBs

SPECIAL GROUPS


DO NOT COMBINE ACEI with ARBs

End

End

End

PHARMACOTHERAPY
if BP 140/90 mmHg in the general population aged <60 y
if BP 150/90 mmHg in general population aged 60 y
if BP 140/90 mmHg in patients with DM, CKD, >60 y

PHARMACOTHERAPY
if BP 140/90 mmHg in the general population aged <60 y
if BP 150/90 mmHg in general population aged 60 y
if BP 140/90 mmHg in patients with DM, CKD, >60 y

PHARMACOTHERAPY
if BP 140/90 mmHg in the general population aged <60 y
if BP 150/90 mmHg in general population aged 60 y
if BP 140/90 mmHg in patients with DM, CKD, >60 y

PHARMACOTHERAPY


First-line therapy
Start with one of:


Thiazide-type diuretics
Calcium channel blockers
ACE inhibitors
ARBs

First-line therapy
Start with one of:

First-line therapy
Start with one of:


Thiazide-type diuretics
Calcium channel blockers
ACE inhibitors
ARBs


Thiazide-type diuretics
Calcium channel blockers
ACE inhibitors
ARBs First-line therapy

Second/third-line alternatives
High doses or combination of:


Thiazide-type diuretics
Calcium channel blockers
ACE inhibitors
ARBs

Second/third-line alternatives
High doses or combination of:

Second/third-line alternatives


Thiazide-type diuretics
Calcium channel blockers
ACE inhibitors
ARBs


Thiazide-type diuretics
Calcium channel blockers
ACE inhibitors
ARBs Second/third-line alternatives

Later-line alternatives


Beta-blockers
Alpha-blockers
Alpha1/Beta-blockers (carvedilol), vasodilating Beta-blockers (nebivolol)
Central Alpha2/-adrenergic agonists (clonidine)
Direct vasodilators ((hydralazine)
Loop diuretics (furosemide)
Aldosterone antagonists (spironolactone)
Peripherally acting adrenergic antagonists (reserpine)

Later-line alternatives

Later-line alternatives


Beta-blockers
Alpha-blockers
Alpha1/Beta-blockers (carvedilol), vasodilating Beta-blockers (nebivolol)
Central Alpha2/-adrenergic agonists (clonidine)
Direct vasodilators ((hydralazine)
Loop diuretics (furosemide)
Aldosterone antagonists (spironolactone)
Peripherally acting adrenergic antagonists (reserpine)


Beta-blockers
Alpha-blockers
Alpha1/Beta-blockers (carvedilol), vasodilating Beta-blockers (nebivolol)
Central Alpha2/-adrenergic agonists (clonidine)
Direct vasodilators ((hydralazine)
Loop diuretics (furosemide)
Aldosterone antagonists (spironolactone)
Peripherally acting adrenergic antagonists (reserpine) Later-line alternatives